Company page

Htg Molecular Diagnostics, Inc.

Htg Molecular Diagnostics, Inc. (ticker: HTGMQ) is a public company based in the United States, with a market capitalization of approximately $221.4 million. The company focuses on molecular diagnostics, providing innovative solutions for the healthcare industry. Htg aims to enhance patient care through its advanced technology and diagnostic capabilities.